Hypothalamic neuropeptide y and its neuroendocrine regulation by leptin

Frontiers of Hormone Research

Volumn 26, Issue , 1999, Pages 71-86

  Widdowson, Peter S ^a   Wilding, John P H ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL SURFACE RECEPTOR; LEPTIN; LEPTIN RECEPTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR;

ANIMAL; BRAIN; DRUG EFFECT; EATING; ENERGY METABOLISM; HUMAN; HYPOTHALAMUS; PHYSIOLOGY; REVIEW;

ANIMALS; BRAIN; CARRIER PROTEINS; EATING; ENERGY METABOLISM; HUMANS; HYPOTHALAMUS; LEPTIN; NEUROPEPTIDE Y; RECEPTORS, CELL SURFACE; RECEPTORS, NEUROPEPTIDE Y;

EID: 0033649481     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061016     Document Type: Article

References (30)

1. Sawchenko PE, Swanson LW, Grzanna R, Howe PR, Bloom SR, Polak JM: Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 1985;241:138-153.
2. Zaijevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B: Chronic intracerebroventricular neuropeptide Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 1993;133:1753-1758.
3. Egawa M, Yoshimatsu H, Bray GH: Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am J Physiol 1991;260:R328-R334.
4. Kalra SP, Dube MG, Sahu A, Phelps CP: Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 1991;88:10931-10935.
5. Lambert PD, Wilding JPH, Gilbey SG, Ghatei MA, Bloom SR: Effect of food deprivation and streptozotocin-induced diabetes on hypothalamic neuropeptide Y release as measured by a radioimmunoassay-linked microdialysis procedure. Brain Res 1994;656:135-140.
6. Lambert PD, Wilding JPH, Al-Dokhayel AAM, Bohuon C, Comoy E, Gilbey SG, Bloom SR: A role for neuropeptide Y, dynorphin and noradrenaline in the central control of food intake after food deprivation. Endocrinology 1993;133:29-32.
7. Akabayashi A, Wahlestedt C, Alexander JT, Leibowitz SF: Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. Brain Res Mol Brain Res 1994;21:55-61.
8. Moltz JM, McDonald JK: Neuropeptide Y: Direct and indirect action on insulin secretion in the rat. Peptides 1985;6:1155-1159.
9. Kalra SP, Kaira PS: Nutritional infertility - The role of the interconnected hypothalamic neuropeptide Y-galanin-opioid network. Front Neuroendocrinol 1996;17:371-401.
10. Wilding JPH, Ajala MO, Lambert PD, Bloom SR: Additive effects of lactation and food restriction to increase hypothalamic neuropeptide Y mRNA in rats. J Endocrinol 1997;152:365-369.
11. Widdowson PS, Upton R, Henderson L, Buckingham R, Wilson S, Williams G: Reciprocal regional changes in brain NPY receptor density during dietary restriction and dietary-induced obesity in the rat. Brain Res 1997;774:1-10.
12. Stanley BG, Magdalin W, Seirafi A, Nguyen MM, Leibowitz SF: Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a varient of the YI receptor mediating this peptide's effect. Peptides 1992;13:581-587.
13. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzlhartmann C, Smith KB, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schafthauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL: A receptor subtype involved in neuropeptide-Y-induced food-intake. Nature 1996;382:168-171.
14. Schafthauser AO, Stricker Krongrad A, Brunner L, Cumin F, Gerald C, Whitebread S, Criscione L, Hofbauer KG: Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligonucleotides. Diabetes 1997;46:1792-1798.
15. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
16. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: Measurement of plasma leptin and ob ma in obese and weight-reduced subjects. Nat Med 1995;1:1155-1161.
17. Halaas IL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-546.
18. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse ob protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-549.
19. Stephens TW, Basinski M, Bristow PK, Bue-Vallesky JM, Burgett SJ, Crafi L, Hale J, Hofmann J, Hsuing UM, Kriauciunas A, et al: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530-532.
20. Tartaglia LA, Dembski M, Weng X, Deng NH, Culpepper J, Devos R, Richards GJ, Campfield LA Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI: Identification and expression cloning of a leptin receptor, ob-r. Cell 1995;83:1263-1271.
21. Mercer JG, Hoggard N, Lawrence CB, Rayner DV, Trayhurn P: Localization of leptin receptor (ob-r) gene-expression in mouse-brain by in-situ hybridization. J Physiol Lond 1996;495P:113.
22. Chua SC, Chung WK, Wupeng XS, Zhang YY, Liu SM, Tartaglia L, Leibel RL: Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996;271: 994-996.
23. Chua SC, White DW, Wupeng XS, Liu SM, Okada N, Kershaw EE, Chung WK, Powerkehoe L, Chua M, Tartaglia LA, Leibel RL: Phenotype of fatty due to gln269pro mutation in the leptin receptor (lepr). Diabetes 1996;45:1141-1143.
24. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, Mckee LJ, Bauer TL, Caro JF: Serum immunoreactive leptin concentrations in normalweight and obese humans. N Engl J Med 1996;334:292-295.
25. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-908.
26. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dma C, Chambaz J, Lacorte J, Basdeveant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B: A mutation in the leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
27. Clement K, Garner C, Hager J, Philippi A, Leduc C, Carey A, Harris TJR, Jury C, Cardon LR, Basdevant A, Demenais F, Guygrand B, North M, Froguel P: Indication for linkage of the human ob gene region with extreme obesity. Diabetes 1996;45:687-690.
28. Reed DR, Ding Y, Xu WZ, Cather C, Green ED, Price RA: Extreme obesity may be linked to markers flanking the human ob gene. Diabetes 1996;45:691-694
29. Schwartz MW, Seeley RI, Campfield LA, Burn P, Baskin DG: Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996;98:1101-1106.
30. Wang Q, Bing C, Al-Barazanji K, Mossakowaska DE, Wang X, McBay D, Neville WA, Taddayon M, Pickavance L, Dryden S, Thomas MEA, McHale MT, Gloyer IS, Wilson S, Buckingham R, Arch JRS, Trayhurn P, Williams G: Interactions between leptin and hypothalamic neuropeptide Y neurones in the control of food intake and energy homeostasis in the rat. Diabetes 1997;46:335-34